| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/21/2002 | CN1364590A Medicine for curing encephalatrophy |
| 08/21/2002 | CN1364584A Nano children Qiying medicine and its preparing method |
| 08/21/2002 | CN1364583A Nano chilren heat clearing away medicine and its preparing method |
| 08/21/2002 | CN1364578A Nano consciousness restoring Zaizao medicine and its preparing method |
| 08/21/2002 | CN1364574A Nano medicine for supplementing qi and arresting bleeding and its preparing method |
| 08/21/2002 | CN1364573A Nano Yulian medicine and its preparing method |
| 08/21/2002 | CN1364571A Nano pearl granulation promoting medicine and its preparing method |
| 08/21/2002 | CN1364559A Nano astragalus root medicine and its preparing method |
| 08/21/2002 | CN1364557A Nano Jingang medicine and its preparing method |
| 08/21/2002 | CN1364555A Nano middle warmer claming six ingredient medicine and its preparing method |
| 08/21/2002 | CN1364545A Nano Xiaoqinglong medicine and its preparing method |
| 08/21/2002 | CN1364536A Nano eight ingredient eagle wood medicine and its preparing method |
| 08/21/2002 | CN1364534A Nano eight ingredient ingredient and eagled wood medicine for clearing away pericardium heat and its preparing method |
| 08/21/2002 | CN1364524A Nano cow-bezoare medicine for clearing away heat-evil in pericardium and its preparing method |
| 08/21/2002 | CN1364520A Nano fengtong medicine and its preparing method |
| 08/21/2002 | CN1364515A Nano antipruritic scar softening medicine and its preparing method |
| 08/21/2002 | CN1364510A Nano seven ingredient beard beautifying medicine and its preparing method |
| 08/21/2002 | CN1364500A Nano sanliangban medicine and its preparing method |
| 08/21/2002 | CN1364497A Nano three seed medicine and its preparing method |
| 08/21/2002 | CN1364492A Nano ten-drops medicine for summer ailments and its preparing method |
| 08/21/2002 | CN1364486A Nano ten ingredient restoration medicine and its preparing method |
| 08/21/2002 | CN1364482A Nano wild jujube seed mecicine and its preparing method |
| 08/21/2002 | CN1364480A Nano gastrodia tuber medicine and its preparing method |
| 08/21/2002 | CN1364478A Nano wanyingding medicine and its prepairng method |
| 08/21/2002 | CN1364471A Nano seven ingredient ketengzi medicine and its preparing method |
| 08/21/2002 | CN1364470A Nono five-seed Yanzong medicine and its preparing method |
| 08/21/2002 | CN1089344C Inhibitor of stem cell proliferation and uses thereof |
| 08/21/2002 | CN1089240C Sucking dog capsule and its production process |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/21/2002 | CN1089237C Compound for use in preparing medium for inhibiting vascular smooth muscle cell migration |
| 08/20/2002 | US6437177 α-hydroxy, -amino, and halo derivatives of β-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437158 Testosterone derivative |
| 08/20/2002 | US6437157 (20s)(8a,9b,13a,14b,17a) 20-(((dimethylamino)-ethyl)-amino) -19-nor-delta.sup.1,3,5(10)-pregnatrien-3-ol; acylation or alkylation of an estrone, cyanation, oximation; fertility control in males |
| 08/20/2002 | US6437148 Intermediates for (R)-3(4-bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one |
| 08/20/2002 | US6437146 Mesangial proliferative glomerulonephritis |
| 08/20/2002 | US6437138 5-bromo-6-chloro-3-(2-(s)-azetidinyl or pyrrolidinyl-methoxy) pyridine intermediates for the 5-substituted compounds which are potent ligands at neuronal nicotinic cholinergic channel receptors, neurotransmitter controlling agents |
| 08/20/2002 | US6437137 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 08/20/2002 | US6437129 Armoatic or heteroarmoatic compound containing substituted amides or thioamides |
| 08/20/2002 | US6437124 Xanthine derivatives which inhibit expression of adhesion molecules on human umbilical vein endothelial cell (huvec) monolayers at very low concentrations |
| 08/20/2002 | US6437111 Bone morphogenetic protein-11 (BMP-11) compositions |
| 08/20/2002 | US6437094 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 08/20/2002 | US6436997 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 08/20/2002 | US6436996 Administering exogenous sources to cells having apolipoprotein alleles, for prophylaxis of alzheimer's disease |
| 08/20/2002 | US6436990 Antiinflammatory, rheumatic and antiarthritic agents, having improved transformation; side effect reduction |
| 08/20/2002 | US6436989 Prodrugs of aspartyl protease inhibitors |
| 08/20/2002 | US6436987 Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid |
| 08/20/2002 | US6436985 Disubstituted pyrazolines and triazolines as factor Xa inhibitors |
| 08/20/2002 | US6436984 Melatonergic drugs that release nitrogen oxide and melatonin, used for prophylaxis of cardiovascular/nervous system, muscular disorders, antiischemic/inflammatory agents, reperfusion injuries, anemia and alzheimer's disease |
| 08/20/2002 | US6436977 Dosing regimens for lasofoxifene |
| 08/20/2002 | US6436973 Leukotriene enzyme inhibitors, administered as antiarthritic and antiinflammatory agents; prophylaxis of psoriasis and liver disorders |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436964 Piperidine derivatives having effects on serotonin related systems |
| 08/20/2002 | US6436960 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 08/20/2002 | US6436957 Indole derivatives as 5-HT1 agonists |
| 08/20/2002 | US6436952 Cyclic nucleotide phosphodiesterase inhibitors; inflammatory airway disorders, such as asthma; antiinflammatory; 6-(4-(2h-2-ethyltetrazol-5-yl) phenyl)-1,2,3,4,4a,10b-hexahydrobenzo(c)(1,6)naohthyridine n-2-oxides |
| 08/20/2002 | US6436951 Camptothecin tetracyclic analogues, preparation, method, applications as medicines and pharmaceutical compositions containing them |
| 08/20/2002 | US6436949 Heterocyclically substituted benzamides and their use |
| 08/20/2002 | US6436945 Substituted O6-benzyl-8-aza-guanines |
| 08/20/2002 | US6436942 Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine |
| 08/20/2002 | US6436938 Combination treatment for depression |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436931 Cytotoxic agents comprising taxanes and their therapeutic use |
| 08/20/2002 | US6436929 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 08/20/2002 | US6436925 Better able to cross membranes; inhibitors of cysteine proteases like calpain i and ii and cathepsin b and l, can thus be used to control diseases associated with an elevated activity of calpain enzymes or cathepsin enzymes |
| 08/20/2002 | US6436924 Useful for treating allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis; nonsedating antihistamines or salts, leukotriene d4 antagonist or 5-lipoxygenase inhibitor or flap protein antagonist |
| 08/20/2002 | US6436923 Compounds and methods for modulation of estrogen receptors |
| 08/20/2002 | US6436913 Use of estramustine phosphate in the treatment of bone metastasis |
| 08/20/2002 | US6436911 IL-12 production inhibitor |
| 08/20/2002 | US6436906 Novel macrolides having antibacterial activity toward grampositive and gramnegative bacteria as well as macrolide resistant grampositives |
| 08/20/2002 | US6436902 Therapeutic preparations for inhalation |
| 08/20/2002 | US6436897 Pharmaceutical formulations for IGF/IGFBP |
| 08/20/2002 | US6436686 Isolated microtubule motor protein having microtubule stimulated adenosine triphosphatase activity and having greater than 90% amino acid sequence identity to specified sequence as measured using sequence comparison algorithm |
| 08/20/2002 | US6436637 Polynucleotide; expression vector; antiinflammatory agents; cell proliferative and apoptosis disorder treatment |
| 08/20/2002 | US6436629 Modulating angiogenesis |
| 08/20/2002 | US6436444 Acidic aqueous chlorite teat dip providing shelf life sanitizing capacity and tissue protection |
| 08/20/2002 | US6436437 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 08/20/2002 | US6436397 Reducing autodegradation during processing and purification. lyophilized solutioni with bulking agent, sucrose, trehalose, or raffinose |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | CA2335397C A method for screening compounds for their potential to inhibit neoplasia and pharmaceutical compositions containing such compounds |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2203991C Methods and devices for immunizing a host to tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides |
| 08/20/2002 | CA2203463C New diosmetin acids and esters, and the pharmaceutical compounds that contain them |
| 08/20/2002 | CA2180378C Forms a and b of n-[[[2-[[[2-[(diaminomethylene)amino]-4-thiazolyl]methyl]thio]ethyl]amino]methylene]-4-bromo-benzenesulfonamide |
| 08/20/2002 | CA2110055C T cell receptor peptides as therapeutics for immune-related disease |
| 08/20/2002 | CA2073983C Novel vitamin d analogues |
| 08/20/2002 | CA2068700C Active oxygen scavenger |
| 08/20/2002 | CA2063886C Polyethylene protein conjugates |
| 08/15/2002 | WO2002063038A1 Method for identifying compounds modulating reverse cholesterol transport |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062997A1 Novel protein and use thereof |
| 08/15/2002 | WO2002062970A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | WO2002062945A2 Compositions and methods relating to lung specific genes and proteins |
| 08/15/2002 | WO2002062852A1 Receptor protein expressed on cells |
| 08/15/2002 | WO2002062851A1 Conformationally abnormal forms of tau proteins and specific antibodies thereto |
| 08/15/2002 | WO2002062842A1 Modified keratinocyte growth factor (kgf) with reduced immunogenicity |